000 01740 a2200505 4500
005 20250516100010.0
264 0 _c20121129
008 201211s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2012.06.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMonsonego, Joseph
245 0 0 _aPrevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
_h[electronic resource]
260 _bVaccine
_cJul 2012
300 _a5215-21 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiopsy
650 0 4 _aCervix Uteri
_xpathology
650 0 4 _aColposcopy
650 0 4 _aCross-Sectional Studies
650 0 4 _aDNA, Viral
_xisolation & purification
650 0 4 _aFemale
650 0 4 _aFrance
_xepidemiology
650 0 4 _aGenotype
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aPapillomaviridae
_xgenetics
650 0 4 _aPapillomavirus Infections
_xdiagnosis
650 0 4 _aPapillomavirus Vaccines
_xadministration & dosage
650 0 4 _aPrevalence
650 0 4 _aRisk Factors
650 0 4 _aUterine Cervical Dysplasia
_xdiagnosis
650 0 4 _aUterine Cervical Neoplasms
_xdiagnosis
650 0 4 _aVaginal Smears
650 0 4 _aYoung Adult
700 1 _aZerat, Laurent
700 1 _aSyrjänen, Kari
700 1 _aZerat, Jean-Claude
700 1 _aSmith, Jennifer S
700 1 _aHalfon, Philippe
773 0 _tVaccine
_gvol. 30
_gno. 35
_gp. 5215-21
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2012.06.013
_zAvailable from publisher's website
999 _c21878300
_d21878300